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Pulmonary hypertension is associated with increased morbidity and mortality in chronic
obstructive pulmonary disease (COPD). Since pulmonary artery (PA) size increases in pul-
monary hypertension, we measured PA cross-sectional area using magnetic resonance
imaging (MRI) to test the hypothesis that pulmonary hyperinflation due to gas trapping is
associated with PA cross-sectional area in COPD.
Methods
The MESA COPD Study recruited participants with COPD and controls from two popula-
tion-based cohort studies ages 50–79 years with 10 or more pack-years and free of clinical
cardiovascular disease. Body plethysmography was performed according to standard crite-
ria. Cardiac MRI was performed at functional residual capacity to measure the cross-sec-
tional area of the main PA. Percent emphysema was defined as the percentage of lung
voxels less than -950 Hounsfield units as assessed via x-ray computed tomography. Analy-
ses were adjusted for age, gender, height, weight, race-ethnicity, the forced expiratory vol-
ume in one second, smoking status, pack-years, lung function, oxygen saturation, blood
pressure, left ventricular ejection fraction and percent emphysema.
Results
Among 106 participants, mean residual volume was 1.98±0.71 L and the mean PA cross-
sectional area was 7.23±1.72 cm2. A one standard deviation increase in residual volume
was independently associated with an increase in main PA cross-sectional area of 0.55 cm2
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(95% CI 0.18 to 0.92; p = 0.003). In contrast, there was no evidence for an association with
percent emphysema or total lung capacity.
Conclusion
Increased residual volume was associated with a larger PA in COPD, suggesting that gas
trapping may contribute to pulmonary hypertension in COPD.
Introduction
Chronic obstructive pulmonary disease (COPD) is characterized by accelerated age-related
loss in lung function and progressive airflow obstruction that is only partially reversible [1].
COPD is the third leading cause of mortality in the United States [2]. COPD may be compli-
cated by the development of pulmonary hypertension (PH), although the severity of PH in
COPD patients is usually mild [3]. The presence of PH in COPD is associated with increased
mortality [4], increased hospitalizations [5], and reduced exercise capacity [6, 7].
The gold standard to diagnose and characterize the degree of PH is right heart catheteriza-
tion, a relatively safe but still invasive procedure. Echocardiographic estimates of pulmonary
artery (PA) pressures are subject to significant error in patients with COPD, given the techni-
cal challenges that arise from pulmonary hyperinflation with hyperexpansion of the chest [8,
9]. PA dilatation is a consequence of PH and its presence can be used to infer PH noninva-
sively with various imaging modalities, including cardiac magnetic resonance imaging (MRI)
[10–13]. In addition, an increased ratio of PA:aortic diameter as measured on computed
tomography (CT) was associated with severe exacerbations of COPD [14].
PH in COPD is caused by a combination of factors, including alveolar hypoxia acutely caus-
ing hypoxic pulmonary vasoconstriction [15], chronically contributing to pulmonary vascular
remodeling [16, 17], hypercapnia and acidosis [18, 19], along with comorbidities including
obstructive sleep apnea, left ventricular systolic or diastolic dysfunction and thromboembolic
disease [20]. Although increases in PA pressure can be provoked by gas trapping and lung
hyperinflation during hyperventilation [21], exercise [22] and acute exacerbations [23], it is
unclear whether gas trapping and hyperinflation contribute to PH in stable COPD patients.
Destruction of the pulmonary vascular bed has also been hypothesized as contributing to PH
in emphysema, however; there is a lack of substantial evidence to support this mechanism
[20]. In the classic literature, emphysematous COPD was not characterized by PH [24] and, in
a recent report from this cohort, emphysematous COPD was associated with smaller not larger
right ventricular volumes [25]. Recent studies have linked early pathology associated with
smoking associated emphysema to both loss of peripheral airways [26] and heterogeneous
parenchymal perfusion [27].
We hypothesized that greater residual volume, a standard clinical measure of pulmonary
hyperinflation and alveolar gas trapping on body plethysmography [28], would be indepen-
dently associated with larger PA cross-sectional area as measured by cardiac MRI. In addition,
to assess a possible confounding factor of parenchymal destruction, we also examined if the
degree of emphysema-like lung (percent emphysema) on computed tomography (CT) and
thoracic hyperexpansion were independently associated with PA cross-sectional area.
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The MESA COPD Study is a cross-sectional study of smokers nested among the Multi-Ethnic
Study of Atherosclerosis (MESA)[29] and the Emphysema and Cancer Action Project
(EMCAP)[30]. Inclusion criteria were age 50–79 years old and10 pack-year smoking his-
tory. Exclusion criteria included clinical cardiovascular disease (heart failure, valve disease,
coronary artery disease, stroke, congenital heart disease or current atrial fibrillation), asthma
prior to age 45 years, pulmonary embolism and other lung diseases, weight > 300 lbs, Stage
III/IV chronic kidney disease insufficiency, and contraindications to MRI, gadolinium, albute-
rol or spirometry. This report includes the 106 participants who completed chest CT, body
plethysmography and cardiac MRI.
Pulmonary function testing
A V6200 Series Autobox (Sensormedics, Yorba Linda, CA) and an OMI rolling barrel spirom-
eter were used to perform body plethysmography and post-bronchodilator spirometry, respec-
tively, following American Thoracic Society/European Respiratory Society (ATS/ERS)
recommendations [31, 32] and as has been previously described [33]. Functional residual
capacity (FRC) was measured while panting at 0.5 to 1 breaths per second. At least two techni-
cally satisfactory maneuvers were performed, followed by an inspiratory capacity and slow
vital capacity maneuver. The mean of the satisfactory measurements was used for the FRC.
The total lung capacity (TLC) was calculated as the sum of the FRC and the inspiratory capac-
ity (IC). The residual volume was calculated as the difference between the TLC and the slow
vital capacity. Hankinson reference equations were used to calculate predicted spirometry val-
ues [33]. ATS/ERS COPD criteria were used to assess COPD status and severity [34]. Predicted
lung volume values and upper and lower limits of normal for each lung volume were calculated
using Garcia-Rio reference equations for participants 65 years and older, and Crapo reference
equations for participants under 65 years [35, 36].
Gas trapping was defined as residual volume or residual volume/TLC above the upper limit
of normal; hyperexpansion was defined as FRC or TLC above the upper limit of normal.[37]
Cardiac MRI and pulmonary artery cross-sectional area analysis
Cardiac MRI was performed at 1.5 Tesla (Signal LX, GE Healthcare, Waukesha, WI) using the
MESA protocol as previously described [29]. An oblique localizer prescribed from axial and
coronal images was used to visualize the natural curvature of the pulmonary artery. This obli-
que localizer was used to prescribe a plane perpendicular to the main PA positioned above the
pulmonary valve but below the pulmonary bifurcation. The right PA was imaged between the
trachea and the ascending aorta using a coronal localizer. A localizer oblique to the plane of
the left PA was prescribed from an axial image and used for obtaining the plane perpendicular
to the left PA. For main, right and left PA, phase-contrast images were obtained using a seg-
mented gradient echo sequence (TR/TE = 7.5/3.1 msec, slice thickness 8 mm, matrix 256x256,
2 views/segment, 30 cardiac phases over the cardiac cycle, two averages, velocity encoding 100
cm/s) without breath holding. For each PA, the maximum/minimum diameter and cross-sec-
tional areas were measured with electronic calibers (Advantage Windows Workstation, GE
Healthcare, Waukesha, WI). The coefficient of variation for the inter-reader variability of the
main PA measures was 6%. The maximum and minimum areas obtained of the PA during the
cardiac cycle were deemed the systolic and diastolic areas respectively.
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To measure left ventricular function, the entire heart was imaged in short-axis orientation
with 12 or more slices. All cine images had temporal resolution of 48 msec and were retrospec-
tively reconstructed at overlapping 20–35 msec intervals over the cardiac cycle with 40 phases.
Semi-automated contouring was used to determine left ventricular volumes and ejection frac-
tion (Cardiac Image Modeller, New Zealand) [38]. Cardiac MR readers were blinded from
other participant information.
To measure the volume of the left atrium (LA), an experienced operator defined the LA
endocardial and epicardial borders at the frame of the largest LA volume using the Multimod-
ality Tissue tracking software (MTT; version 6.0, Toshiba, Japan) on long-axis 2-chamber and
4-chamber cine MR images. The volume was calculated using the biplane method as follows:
LA volume = (0.848  area4chamber  area2chamber)/(length2chamber + length4chamber)/2
[39].
Assessment of percent emphysema on CT
A GE 64-slice helical scanner (120 kVp, 200mAs at 0.5 seconds) with 0.75 mm slice thickness
was used to perform full-lung thoracic CT on the participants. Images were obtained at sus-
pended full inspiration. Percent emphysema was assessed via the Apollo software (VIDA Diag-
nostics, Coralville IA) at a single, independent reading center blinded to other participant The
percentage of total voxels within the lung field with values below -950 Hounsfield units (HU)
was designated as percent emphysema (also known as percent low attenuation areas) [40].
Anthropometry, blood pressure and other co-variates: Age, gender and race or ethnic group
were self-reported. Height, weight, seated blood pressure were measured according to the
MESA protocol [41]. Smoking history was self-reported using a standard questionnaire and
smoking status was confirmed with plasma and urine cotinine levels (Immulite 2000 Nicotine
Metabolite Assay; Diagnostic Products Corp., Los Angeles, CA, USA). Oxygen saturation was
measured non-invasively at rest with pulse oximetry. Serum bicarbonate was measured on
clinical chemistries.
Study oversight
The institutional review boards of the participating institutions, which include Columbia Uni-
versity, UCLA, Johns Hopkins, University of Iowa, Northwestern University, University of
Washington, and the National Heart, Lung, and Blood Institute, approved the study proce-
dures. Written informed consent was obtained from all participants in the MESA COPD
Study.
Statistical analysis
The cohort was stratified by quartiles of percent predicted residual volume for descriptive pur-
poses. The initial analysis of the relationship between systolic and diastolic PA cross-sectional
area and residual volume was performed using multiple linear regression with adjustment for
the following potential confounders and precision variables: age, gender, height, weight, race-
ethnicity, FEV1, resting oxygen saturation, cohort and percent emphysema. The full model
additionally included smoking history and status, blood pressure and left ventricular ejection
fraction. To minimize the possibility of confounding by body size, the analyses were repeated
for another measure of hyperinflation, residual volume to TLC ratio (RV/TLC). Analyses for
PA cross-sectional area and percent emphysema proceeded in a similar fashion. Analyses were
weighted according to the inverse ratio of sample prevalence to source study prevalence, as
previously described [37], to avoid bias for the recruitment based on COPD status. To account
for multiple comparisons of the two primary endpoints, systolic and diastolic cross-sectional
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areas of the main PA, we used a two-tailed, Bonferroni-corrected P-value of 0.025 to define sta-
tistical significance. If significant, we additionally performed secondary analyses of the right
and left PA cross-sectional areas.
Results
Of the 106 participants, the mean age was 69.5±5 years and 57% were male. Table 1 summa-
rizes the characteristics of the study participants stratified by quartile of percent predicted
residual volume. Sixty-five percent of the participants had COPD, mostly of mild or moderate
severity. The proportion of males and current smokers increased across categories of residual
volume, as did severity of COPD, alternate measures of hyperinflation and percent emphy-
sema. Height and weight increased across categories of residual volume but BMI did not; oxy-
gen saturation and bicarbonate were similar across categories, and left ventricular ejection
fraction was marginally lower only in the category with the greatest residual volume. Twenty-
seven participants (25%) had a residual volume greater than 100% predicted and 18 partici-
pants (17%) had a residual volume greater than 110% predicted.
Pulmonary hyperinflation/gas trapping and PA dimension
Both systolic and diastolic main PA cross-sectional areas rose monotonically across categories
of residual volume (Table 2). A significant association was observed between residual volume,
and the systolic cross-sectional area of the main PA. In the fully adjusted model, a one standard
deviation increase in residual volume (0.71 L) was associated with a 0.55 cm2 increase in the
main PA systolic cross-sectional area (95% CI 0.18 to 0.92; p = 0.003). Results were very similar
and equally significant for the main PA diastolic cross-sectional area (Table 2). We addition-
ally examined the right and left PA: there were similar significant associations between residual
volume and the right PA cross-sectional area but no association between residual volume and
the left PA cross-sectional area.
Similar associations of often greater statistical significance were observed between RV/TLC
and PA cross-sectional areas (S1 Table).
Additional sensitivity analyses revealed no significant interaction between these associa-
tions and gender, smoking status, cohort, presence of COPD, serum bicarbonate, left ventricu-
lar mass, left ventricular stroke volume, left ventricular end-diastolic volume. (Fig 1). When
stratifying the results for with COPD, the point estimate for the effect of RV on PA cross-sec-
tional area did not change but the confidence intervals widened, likely indicating that the
study was underpowered for this subgroup and not that there was an effect modification of the
relationship by COPD status.
Percent emphysema and hyperexpansion and PA dimensions
In contrast to the results for pulmonary hyperinflation and gas trapping, there was no evidence
for an association between percent emphysema and any PA cross-sectional area (Table 3).
There was also no evidence for an association between PA cross-sectional areas and other mea-
sures of hyperinflation suggestive of hyperexpansion, including TLC and FRC.
Right ventricular measures and PA dimensions
There was no evidence for an association between right ventricular parameters and main PA
cross-sectional area. (S2 and S3 Tables)
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Table 1. Baseline characteristics of MESA COPD Study participants with plethysmograph and MRI measures*. Stratified by quartiles percent pre-
dicted residual volume.
Characteristic Quartiles of Percent Predicted Residual Volume
1 2 3 4










Age—years 70±4 71±5 71±5 67±6
Male sex—no. (%) 9 (35) 13 (48) 16 (62) 19 (70)
Race or ethnic group—no. (%)†
Caucasian 17 (65) 23 (85) 21 (81) 20 (74)
African American 4 (15) 2 (7) 3 (12) 7 (26)
Other 5 (19) 2 (7) 2 (8) 0 (0)
Height—cm 166±10 167±10 169±8 171±10
Weight—kg 75±17 77±15 76±18 78±21
BMI—kg/m2 27±6 27±5 27±5 26±5
Cigarette smoking status—no. (%)†
Former smoker 19 (73) 18 (67) 17 (65) 13 (48)
Current smoker 7 (27) 9 (33) 9 (35) 14 (52)
Pack-years of smoking—no.†
Median (IQR) 36 (32) 40 (25) 43 (30) 51 (34)
Serum bicarbonate—mEq/L 27 (1) 27 (2) 27 (3) 28 (3)
Blood pressure—mm Hg
Systolic 119±18 123±15 125±18 122±14
Diastolic 67±10 69±11 73±11 74±8
COPD—no. (%) 10 (38) 13 (48) 17 (65) 25 (93)
GOLD—COPD severity—no. (%)
Mild 5 (19) 8 (30) 8 (31) 3 (11)
Moderate 5 (19) 5 (19) 8 (31) 13 (48)
Severe / very severe 0 (0) 0 (0) 1 (4) 9 (33)
Plethysmography:
Residual volume—L 1.24±0.23 1.69±0.16 2.08±0.23 2.89±0.66
FRC—L 2.81±0.78 2.96±0.58 3.38±0.56 4.15±0.73
% Predicted FRC 89.9±18.9 93.4±16.0 104.3±15.5 125.2±19.0
TLC—L 4.82±1.07 5.42±1.11 5.84±1.09 6.34±1.12
% Predicted TLC 85.9±11.9 93.1±10.4 96.9±9.1 102.3±12.7
Residual volume to TLC ratio 0.26±0.05 0.32±0.05 0.37±0.06 0.46±0.08
Post-bronchodilator spirometry:
FEV1—L 2.32±0.60 2.41±0.70 2.31±0.78 1.72±0.67
% Predicted FEV1 95.8±15.7 94.0±20.4 88.1±25.2 60.4±18.5
FVC—L 3.27±0.82 3.56±0.92 3.57±1.01 3.37±0.93
% Predicted FVC 101.8±14.9 103.9±17.8 100.7±17.9 88.1±17.9
FEV1 to FVC ratio 0.71 ±0.08 0.68±0.10 0.64±0.11 0.51±0.10
Diffusion capacity:
DLCO—mL/min/mmHg 16.62±4.79 16.99±5.28 16.84±4.41 15.54±6.11
%Predicted DLCO 64.0±10.6 63.2±12.6 61.7±13.8 52.7±17.9
Percent emphysema
-950 HU—median (IQR) 1.1 (2.5) 1.3 (2.6) 1.8 (2.0) 7.89 (13)
Oxygen saturation—median (IQR) 97 (3) 97 (3) 97 (3) 97 (2)
Left ventricular ejection fraction—% 61±6 61±7 63±8 59±6
Left atrial volume—mL 59.7±28.7 62.1±21.6 57.4±22.7 62.9±21.1
* Plus-minus values are means ± standard deviation.
†Race or ethnic group, smoking status and pack-year history were self-reported.
Abbreviations: COPD denotes chronic obstructive pulmonary disease, FRC functional residual capacity, TLC total lung capacity, FEV1 forced expired
volume in the first second, FVC forced vital capacity, and HU Hounsfield units.
https://doi.org/10.1371/journal.pone.0176812.t001
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Discussion
Pulmonary hyperinflation and specifically gas trapping, as assessed by increased residual vol-
ume and residual volume to TLC ratio, was associated with a larger main PA cross-sectional
area on MRI. In contrast, there was no evidence that the extent of emphysema as measured by
CT or measures of hyperexpansion (increased FRC and TLC) were associated with PA dimen-
sions. These findings suggest that gas trapping, but not emphysema, are associated with pul-
monary vascular remodeling in current and former smokers.
The present report is the first, to the best of our knowledge, to consider the relationship
between pulmonary hyperinflation, gas trapping and PA size. A few prior studies have shown
a relationship between pulmonary hyperinflation and increased PA pressure. The classic
experiments by West elucidated the relationship between alveolar pressure and regional pul-
monary blood flow, demonstrating that increasing alveolar pressure in the presence of con-
stant pulmonary arterial pressure results in decreasing regional pulmonary blood flow. These
experiments helped define the concept of the “West lung zones” [42]. Hakim and colleagues,
Table 2. Relationship between residual volume and pulmonary artery cross-sectional area*.
Pulmonary Artery Mean difference in quartiles of
Residual Volume
Mean difference in pulmonary artery cross-sectional area per standard




% Predicted Residual Volume
—median











Model 1 0 0.33 0.53 0.64 0.43 (-0.01 to 0.86) 0.055











Model 1 0 0.37 0.45 0.56 0.38 (-0.01 to 0.78) 0.059











Model 1 0 1.20 0.96 1.83 0.63 (0.16 to 1.11) 0.009











Model 1 0 1.03 0.77 1.60 0.55 (0.12 to 0.98) 0.01
Model 2 0 1.02 0.75 1.56 0.56 (0.16 to 0.97) 0.006










Model 1 0 0.30 -0.30 0.18 -0.24 (-0.73 to 0.25) 0.34











Model 1 0 0.15 -0.38 0.05 -0.26 (-0.70 to 0.18) 0.25
Model 2 0 0.10 -0.60 -0.01 -0.31 (-0.70 to 0.08) 0.12
*Mean differences in model 1 were adjusted for age, gender, race or ethnic group, height, weight, cohort, percent emphysema
-950 HU, forced expired
volume in the first second and oxygen saturation. Model 2 was additionally adjusted for smoking status, pack-years of smoking history, systolic blood
pressure, diastolic blood pressure and left ventricular ejection fraction. Plus-minus values are means ± standard deviation. Abbreviations: CI denotes
confidence interval, HU Hounsfield units, RV residual volume and FEV1 forced expired volume in the first second.
https://doi.org/10.1371/journal.pone.0176812.t002
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using a canine model, determined that pulmonary vascular resistance increases with lung
inflation, both via positive-pressure and negative-pressure breathing, suggesting that alveolar
vessels behave as Starling resistors [43]. Fuld et al., utilizing both dynamic computed tomogra-
phy to directly assess pulmonary perfusion and dual energy CT to assess regional pulmonary
blood volume, demonstrated the role of increasing lung volume in limiting both perfusion and
regional blood volume in the non-dependent lung regions with the extent of the effect increas-
ing with the level of lung inflation [44]. The association between increased PA cross-sectional
area and hyperinflation with gas trapping found in our study may be a result of the compres-
sion of alveolar vessels from increased alveolar pressure and volume, leading to an increase in
pulmonary vascular resistance and consequently an increase in PA pressure. While a similar
association between PA pressure and hyperinflation with gas trapping was found for the right
PA, there was no association for the left PA. This discrepancy may have occurred because the
right PA is less constrained by mediastinal structures than the left PA, possibly making its
cross-sectional area a better gauge of intravascular pressure.
The effect of gas trapping and hyperinflation on PA pressure and pulmonary vascular resis-
tance in patients with COPD has been previously studied in small but interventional studies.
Harris and colleagues reported that voluntary hyperventilation to achieve high minute ventila-
tion in patients with chronic bronchitis resulted in increased PA pressures and increased pul-
monary vascular resistance but that it had no such effect in normal patients [45]. Similarly,
Butler and colleagues found an increase in PA pressure and pulmonary capillary wedge pres-
sure with hyperventilation in patients with COPD but not in normal patients [21]. In a recent
study examining explanted lungs from 17 patients with severe COPD, half of them with mild
pulmonary hypertension, pulmonary vascular involvement was unexpectedly modest,
Fig 1. Mean difference in systolic main pulmonary artery cross-sectional area by residual volume.
Original model was adjusted for age, gender, race or ethnic group, height, weight, cohort, cohort, percent
emphysema
-950 HU, forced expired volume in the first second and oxygen saturation, smoking status, pack-
years of smoking history, systolic blood pressure, diastolic blood pressure and left ventricular ejection fraction.
https://doi.org/10.1371/journal.pone.0176812.g001
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indicating a mechanism other than a primary vasculopathy as the cause of pulmonary hyper-
tension [46]. These studies suggest that dynamic hyperinflation may be the major contributor
to hemodynamic changes.
It has been postulated that emphysematous destruction of the pulmonary vasculature con-
tributes to elevated pulmonary vascular pressures in COPD [47]. However, our study found
no association between the extent of emphysema as measured quantitatively on CT and PA
cross-sectional area. Our finding is consistent with prior studies examining the relationship
between PA pressures and the extent of emphysema. Scharf and colleagues found no associa-
tion between mean PA pressures and CT emphysema scores in the 120 patients with severe
emphysema from the National Emphysema Treatment trial [48]. Biernacki and colleagues
found no association between mean PA pressures, both at rest and with exercise, and CT mea-
sures of emphysema in 32 patients with COPD.[49] Burrows and colleagues, in their classic
paper examining the different hemodynamic phenotypes in COPD, noted that patients with a
predominantly “emphysematous” type of COPD often had PA pressures within normal limits
and only slight elevations in pulmonary vascular resistance [24]. Furthermore, we recently
Table 3. Relationship between percent emphysema and pulmonary artery cross-sectional area*.
Pulmonary Artery Mean difference in pulmonary artery cross-sectional area per






Model 1 0.02 (-0.23 to 0.27) 0.85
Model 2 0.02 (-0.24 to 0.28) 0.88
Main Pulmonary Artery
Diastolic—cm2
Model 1 0.06 (-0.17 to 0.29) 0.60
Model 2 0.08 (-0.15 to 0.31) 0.49
Right Pulmonary Artery
Systolic—cm2
Model 1 -0.01 (-0.18 to 0.15) 0.88
Model 2 0.002 (-0.16 to 0.17) 0.98
Right Pulmonary Artery
Diastolic—cm2
Model 1 0.02 (-0.12 to 0.17) 0.75
Model 2 0.05 (-0.91 to 0.19) 0.50
Left Pulmonary Artery
Systolic—cm2
Model 1 0.08 (-0.10 to 0.27) 0.38
Model 2 0.11 (-0.07 to 0.29) 0.24
Left Pulmonary Artery
Diastolic—cm2
Model 1 0.09 (-0.08 to 0.25) 0.31
Model 2 0.12 (-0.05 to 0.28) 0.16
*Mean differences in model 1 were adjusted for age, gender, race or ethnic group, height, weight, cohort,
forced expired volume in the first second and oxygen saturation. Model 2 was additionally adjusted for
smoking status, pack-years of smoking history, systolic blood pressure, diastolic blood pressure and left
ventricular ejection fraction. Abbreviations: CI denotes confidence interval.
https://doi.org/10.1371/journal.pone.0176812.t003
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reported that COPD and particularly emphysema was associated, on average, with smaller
right ventricular volumes and that this was particularly true for emphysema [25]. Of note, the
association of gas trapping with increased PA dimensions reported here did not translate into
right ventricular enlargement, possibly related to the generally mild-moderate severity of gas
trapping in this cohort.
The present findings and above studies suggest that impaired left ventricular filling
and concomitant reductions in stroke volume related to percent emphysema, which have
been previously observed in a large, population-based cohort free of clinical cardiovascular
disease [50] and in the present cohort [51], may be related to vascular destruction in
emphysema that reduces pulmonary blood flow but which does not markedly increase PA
pressure.
The present study has several limitations. First, because pulmonary cross-sectional area was
measured rather than PA pressure, the proposed mechanism of increased PA pressure from
downstream alveolar vessel compression leading to PA dilatation remains speculative. Con-
ceivably, hyperinflation could cause architectural changes of the pulmonary vasculature lead-
ing to an increase in PA cross-sectional area without necessarily an increase in PA pressure.
The testing necessary to demonstrate whether the increased PA cross-sectional area is from
increased PA pressure or another cause are too invasive to be applied to a population-based
study of participants free of clinical cardiovascular disease with predominantly mild to moder-
ate COPD. Further work is needed to elucidate the direct relationship between hyperinflation
and PA pressure by directly measuring or estimating PA pressures in patients with mild to
moderate COPD. Second, residual confounding by left ventricular diastolic dysfunction may
have contributed to the observed association. Smith and colleagues, in the same cohort as this
study, observed that greater residual volume and RV/TLC ratio is associated with greater left
ventricular mass [37]. However, in our study, sensitivity analyses revealed no effect when
adjusting for left ventricular end-diastolic mass, left ventricular end-diastolic volume and left
ventricular stroke volume. Third, we did not perform arterial blood gasses; however, there was
no suggestion that hypoxemia and hypercapnea varied substantially with residual volume in
this cohort and sensitivity analyses revealed no effect when adjusting for serum bicarbonate.
Fourth, the cross-sectional design of the study does not allow for determination of cause and
effect for the observed association; however, it seems much more likely from a physiologic
standpoint that hyperinflation would cause increased PA cross-sectional area as opposed to
the other way around.
Conclusions
In conclusion, increased residual volume, a measure of pulmonary hyperinflation and gas trap-
ping, was independently associated with increased PA cross-sectional area. In contrast, there
was no evidence of a relationship of emphysema severity to PA dimensions. These results sug-
gest that gas trapping may be a cause of increased PA pressure in COPD, possibly from alveo-
lar vessel compression by distended alveoli.
Supporting information
S1 Table. Relationship between residual volume–Total lung capacity ratio and pulmonary
artery cross-sectional area. Mean differences in model 1 were adjusted for age, gender, race
or ethnic group, height, weight, cohort, percent emphysema-950 HU, forced expired volume in
the first second and oxygen saturation. Model 2 was additionally adjusted for smoking status,
pack-years of smoking history, systolic blood pressure, diastolic blood pressure and left ven-
tricular ejection fraction. Abbreviations: CI denotes confidence interval, HU Hounsfield units,
Pulmonary hyperinflation due to gas trapping and pulmonary artery size
PLOS ONE | https://doi.org/10.1371/journal.pone.0176812 May 2, 2017 10 / 14
RV residual volume, TLC total lung capacity and FEV1 forced expired volume in the first
second.
(DOCX)
S2 Table. Relationship between right ventricle parameters and main pulmonary artery sys-
tolic cross-sectional area. Models were adjusted for age, gender, race or ethnic group, height,
weight, cohort, percent emphysema-950 HU, forced expired volume in the first second, oxygen
saturation, smoking status, pack-years of smoking history, systolic blood pressure, and dia-
stolic blood pressure. Abbreviations: CI denotes confidence interval, HU Hounsfield units, RV
right ventricle.
(DOCX)
S3 Table. Relationship between right ventricle parameters and main pulmonary artery dia-
stolic cross-sectional area. Models were adjusted for age, gender, race or ethnic group, height,
weight, cohort, percent emphysema-950 HU, forced expired volume in the first second, oxygen
saturation, smoking status, pack-years of smoking history, systolic blood pressure, and dia-




Conceptualization: HP SK CYL BS BA EH JL EM MP RGB.
Data curation: HP SK CYL BS BA EH JL EM MP RGB.
Formal analysis: HP BS RGB.
Funding acquisition: RGB.
Methodology: CYL BA MP.
Project administration: RGB.
Supervision: RGB.
Writing – original draft: HP.
Writing – review & editing: HP SK CYL BS BA EH JL EM MP RGB.
References
1. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012; 379
(9823):1341–51. Epub 2012/02/09. https://doi.org/10.1016/S0140-6736(11)60968-9 PMID: 22314182
2. http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_02.pdf
3. Minai OA, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and
management: pulmonary vascular disease: the global perspective. Chest. 2010; 137(6 Suppl):39S–
51S. Epub 2010/06/11. https://doi.org/10.1378/chest.10-0087 PMID: 20522579
4. Oswald-Mammosser M, Weitzenblum E, Quoix E, Moser G, Chaouat A, Charpentier C, et al. Prognostic
factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure.
Chest. 1995; 107(5):1193–8. Epub 1995/05/01. PMID: 7750305
5. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for
acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. American jour-
nal of respiratory and critical care medicine. 1999; 159(1):158–64. Epub 1999/01/05. https://doi.org/10.
1164/ajrccm.159.1.9803117 PMID: 9872834
Pulmonary hyperinflation due to gas trapping and pulmonary artery size
PLOS ONE | https://doi.org/10.1371/journal.pone.0176812 May 2, 2017 11 / 14
6. Sims MW, Margolis DJ, Localio AR, Panettieri RA, Kawut SM, Christie JD. Impact of pulmonary artery
pressure on exercise function in severe COPD. Chest. 2009; 136(2):412–9. Epub 2009/03/26. https://
doi.org/10.1378/chest.08-2739 PMID: 19318664
7. Boerrigter BG, Bogaard HJ, Trip P, Groepenhoff H, Rietema H, Holverda S, et al. Ventilatory and cardio-
circulatory exercise profiles in COPD: the role of pulmonary hypertension. Chest. 2012. Epub 2012/05/
05.
8. Fisher MR, Criner GJ, Fishman AP, Hassoun PM, Minai OA, Scharf SM, et al. Estimating pulmonary
artery pressures by echocardiography in patients with emphysema. The European respiratory journal:
official journal of the European Society for Clinical Respiratory Physiology. 2007; 30(5):914–21. Epub
2007/07/27.
9. Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, et al. Echocardiographic
assessment of pulmonary hypertension in patients with advanced lung disease. American journal of
respiratory and critical care medicine. 2003; 167(5):735–40. Epub 2002/12/14. https://doi.org/10.1164/
rccm.200210-1130OC PMID: 12480614
10. Sanz J, Kuschnir P, Rius T, Salguero R, Sulica R, Einstein AJ, et al. Pulmonary arterial hypertension:
noninvasive detection with phase-contrast MR imaging. Radiology. 2007; 243(1):70–9. Epub 2007/03/
03. https://doi.org/10.1148/radiol.2431060477 PMID: 17329691
11. Sanz J, Kariisa M, Dellegrottaglie S, Prat-Gonzalez S, Garcia MJ, Fuster V, et al. Evaluation of pulmo-
nary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovascular
imaging. 2009; 2(3):286–95. Epub 2009/04/10. https://doi.org/10.1016/j.jcmg.2008.08.007 PMID:
19356573
12. Boerrigter B, Mauritz GJ, Marcus JT, Helderman F, Postmus PE, Westerhof N, et al. Progressive dilata-
tion of the main pulmonary artery is a characteristic of pulmonary arterial hypertension and is not related
to changes in pressure. Chest. 2010; 138(6):1395–401. Epub 2010/05/25. https://doi.org/10.1378/
chest.10-0363 PMID: 20495109
13. Frank H, Globits S, Glogar D, Neuhold A, Kneussl M, Mlczoch J. Detection and quantification of pulmo-
nary artery hypertension with MR imaging: results in 23 patients. AJR American journal of roentgenol-
ogy. 1993; 161(1):27–31. Epub 1993/07/01. https://doi.org/10.2214/ajr.161.1.8517315 PMID: 8517315
14. Wells JM, Washko GR, Han MK, Abbas N, Nath H, Mamary AJ, et al. Pulmonary arterial enlargement
and acute exacerbations of COPD. The New England journal of medicine. 2012; 367(10):913–21. Epub
2012/09/04. https://doi.org/10.1056/NEJMoa1203830 PMID: 22938715
15. Hales CA. The site and mechanism of oxygen sensing for the pulmonary vessels. Chest. 1985; 88(4
Suppl):235S–40S. Epub 1985/10/01. PMID: 4042729
16. Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and
molecular mechanisms. Circulation research. 2006; 99(7):675–91. Epub 2006/09/30. https://doi.org/10.
1161/01.RES.0000243584.45145.3f PMID: 17008597
17. Penaloza D, Arias-Stella J. The heart and pulmonary circulation at high altitudes: healthy highlanders
and chronic mountain sickness. Circulation. 2007; 115(9):1132–46. Epub 2007/03/07. https://doi.org/
10.1161/CIRCULATIONAHA.106.624544 PMID: 17339571
18. Balanos GM, Talbot NP, Dorrington KL, Robbins PA. Human pulmonary vascular response to 4 h of
hypercapnia and hypocapnia measured using Doppler echocardiography. J Appl Physiol. 2003; 94
(4):1543–51. Epub 2002/12/17. https://doi.org/10.1152/japplphysiol.00890.2002 PMID: 12482766
19. Mekontso Dessap A, Charron C, Devaquet J, Aboab J, Jardin F, Brochard L, et al. Impact of acute
hypercapnia and augmented positive end-expiratory pressure on right ventricle function in severe acute
respiratory distress syndrome. Intensive care medicine. 2009; 35(11):1850–8. Epub 2009/08/05.
https://doi.org/10.1007/s00134-009-1569-2 PMID: 19652953
20. Wrobel JP, Thompson BR, Williams TJ. Mechanisms of pulmonary hypertension in chronic obstructive
pulmonary disease: a pathophysiologic review. The Journal of heart and lung transplantation: the official
publication of the International Society for Heart Transplantation. 2012; 31(6):557–64. Epub 2012/04/
17.
21. Butler J, Schrijen F, Henriquez A, Polu JM, Albert RK. Cause of the raised wedge pressure on exercise
in chronic obstructive pulmonary disease. The American review of respiratory disease. 1988; 138
(2):350–4. Epub 1988/08/01. https://doi.org/10.1164/ajrccm/138.2.350 PMID: 3195834
22. Schrijen FV, Henriquez A, Carton D, Delorme N, Butler J. Pulmonary vascular resistance rises with lung
volume on exercise in obstructed airflow disease. Clin Physiol. 1989; 9(2):143–50. Epub 1989/04/01.
PMID: 2721127
23. Akcay M, Yeter E, Durmaz T, Keles T, Akar Bayram N, Uyar M, et al. Treatment of acute chronic
obstructive pulmonary disease exacerbation improves right ventricle function. European journal of
echocardiography: the journal of the Working Group on Echocardiography of the European Society of
Cardiology. 2010; 11(6):530–6. Epub 2010/03/13.
Pulmonary hyperinflation due to gas trapping and pulmonary artery size
PLOS ONE | https://doi.org/10.1371/journal.pone.0176812 May 2, 2017 12 / 14
24. Burrows B, Kettel LJ, Niden AH, Rabinowitz M, Diener CF. Patterns of cardiovascular dysfunction in
chronic obstructive lung disease. The New England journal of medicine. 1972; 286(17):912–8. https://
doi.org/10.1056/NEJM197204272861703 PMID: 5013974
25. Kawut SM, Poor HD, Parikh MA, Hueper K, Smith BM, Bluemke DA, et al. Cor pulmonale parvus in
chronic obstructive pulmonary disease and emphysema: the MESA COPD study. Journal of the Ameri-
can College of Cardiology. 2014; 64(19):2000–9. https://doi.org/10.1016/j.jacc.2014.07.991 PMID:
25440095
26. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, et al. Small-airway
obstruction and emphysema in chronic obstructive pulmonary disease. The New England journal of
medicine. 2011; 365(17):1567–75. https://doi.org/10.1056/NEJMoa1106955 PMID: 22029978
27. Alford SK, van Beek EJ, McLennan G, Hoffman EA. Heterogeneity of pulmonary perfusion as a mecha-
nistic image-based phenotype in emphysema susceptible smokers. Proceedings of the National Acad-
emy of Sciences of the United States of America. 2010; 107(16):7485–90. https://doi.org/10.1073/pnas.
0913880107 PMID: 20368443
28. Leith DE, Brown R. Human lung volumes and the mechanisms that set them. The European respiratory
journal: official journal of the European Society for Clinical Respiratory Physiology. 1999; 13(2):468–72.
Epub 1999/03/05.
29. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, et al. Multi-ethnic study of ath-
erosclerosis: objectives and design. American journal of epidemiology. 2002; 156(9):871–81. Epub
2002/10/25. PMID: 12397006
30. Mesia-Vela S, Yeh CC, Austin JH, Dounel M, Powell CA, Reeves A, et al. Plasma carbonyls do not cor-
relate with lung function or computed tomography measures of lung density in older smokers. Biomark-
ers: biochemical indicators of exposure, response, and susceptibility to chemicals. 2008; 13(4):422–34.
Epub 2008/05/20.
31. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the
measurement of lung volumes. The European respiratory journal: official journal of the European Soci-
ety for Clinical Respiratory Physiology. 2005; 26(3):511–22. Epub 2005/09/02.
32. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirome-
try. The European respiratory journal: official journal of the European Society for Clinical Respiratory
Physiology. 2005; 26(2):319–38. Epub 2005/08/02.
33. Hankinson JL, Kawut SM, Shahar E, Smith LJ, Stukovsky KH, Barr RG. Performance of American Tho-
racic Society-recommended spirometry reference values in a multiethnic sample of adults: the multi-
ethnic study of atherosclerosis (MESA) lung study. Chest. 2010; 137(1):138–45. Epub 2009/09/11.
https://doi.org/10.1378/chest.09-0919 PMID: 19741060
34. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of
the ATS/ERS position paper. The European respiratory journal: official journal of the European Society
for Clinical Respiratory Physiology. 2004; 23(6):932–46. Epub 2004/06/29.
35. Garcia-Rio F, Dorgham A, Pino JM, Villasante C, Garcia-Quero C, Alvarez-Sala R. Lung volume refer-
ence values for women and men 65 to 85 years of age. American journal of respiratory and critical care
medicine. 2009; 180(11):1083–91. https://doi.org/10.1164/rccm.200901-0127OC PMID: 19745204
36. Crapo RO, Morris AH, Clayton PD, Nixon CR. Lung volumes in healthy nonsmoking adults. Bulletin eur-
opeen de physiopathologie respiratoire. 1982; 18(3):419–25. Epub 1982/05/01. PMID: 7074238
37. Smith BM, Kawut SM, Bluemke DA, Basner RC, Gomes AS, Hoffman E, et al. Pulmonary Hyperinflation
and Left Ventricular Mass: The Multi-Ethnic Study of Atherosclerosis COPD Study. Circulation. 2013;
127(14):1503–11. Epub 2013/03/16. https://doi.org/10.1161/CIRCULATIONAHA.113.001653 PMID:
23493320
38. Young AA, Cowan BR, Thrupp SF, Hedley WJ, Dell’Italia LJ. Left ventricular mass and volume: fast cal-
culation with guide-point modeling on MR images. Radiology. 2000; 216(2):597–602. Epub 2000/08/05.
https://doi.org/10.1148/radiology.216.2.r00au14597 PMID: 10924592
39. Zareian M, Ciuffo L, Habibi M, Opdahl A, Chamera EH, Wu CO, et al. Left atrial structure and functional
quantitation using cardiovascular magnetic resonance and multimodality tissue tracking: validation and
reproducibility assessment. J Cardiovasc Magn Reson. 2015; 17:52. https://doi.org/10.1186/s12968-
015-0152-y PMID: 26126732
40. Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density
and macroscopic morphometry in pulmonary emphysema. American journal of respiratory and critical
care medicine. 1995; 152(2):653–7. Epub 1995/08/01. https://doi.org/10.1164/ajrccm.152.2.7633722
PMID: 7633722
41. Exam 5 Field Center Procedures Manual of Operations. MESA—NHLBI, 2010. (Accessed April 26,
2012, 2012, at http://www.mesa-nhlbi.org/publicdocs/2011/mesae5_mopjanuary2011.pdf
Pulmonary hyperinflation due to gas trapping and pulmonary artery size
PLOS ONE | https://doi.org/10.1371/journal.pone.0176812 May 2, 2017 13 / 14
42. West JB, Dollery CT, Naimark A. Distribution of Blood Flow in Isolated Lung; Relation to Vascular and
Alveolar Pressures. J Appl Physiol. 1964; 19:713–24. Epub 1964/07/01. PMID: 14195584
43. Hakim TS, Michel RP, Chang HK. Effect of lung inflation on pulmonary vascular resistance by arterial
and venous occlusion. J Appl Physiol. 1982; 53(5):1110–5. Epub 1982/11/01. PMID: 6757207
44. Fuld MK, Halaweish AF, Haynes SE, Divekar AA, Guo J, Hoffman EA. Pulmonary perfused blood vol-
ume with dual-energy CT as surrogate for pulmonary perfusion assessed with dynamic multidetector
CT. Radiology. 2013; 267(3):747–56. https://doi.org/10.1148/radiol.12112789 PMID: 23192773
45. Harris P, Segel N, Green I, Housley E. The influence of the airways resistance and alveolar pressure on
the pulmonary vascular resistance in chronic bronhcitis. Cardiovascular research. 1968; 2(1):84–92.
Epub 1968/01/01. PMID: 5645469
46. Peinado VI, Gomez FP, Barbera JA, Roman A, Angels Montero M, Ramirez J, et al. Pulmonary vascular
abnormalities in chronic obstructive pulmonary disease undergoing lung transplant. The Journal of
heart and lung transplantation: the official publication of the International Society for Heart Transplanta-
tion. 2013; 32(12):1262–9.
47. Chaouat A, Bugnet AS, Kadaoui N, Schott R, Enache I, Ducolone A, et al. Severe pulmonary hyperten-
sion and chronic obstructive pulmonary disease. American journal of respiratory and critical care medi-
cine. 2005; 172(2):189–94. Epub 2005/04/16. https://doi.org/10.1164/rccm.200401-006OC PMID:
15831842
48. Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE. Hemodynamic characterization of patients
with severe emphysema. American journal of respiratory and critical care medicine. 2002; 166(3):
314–22. Epub 2002/08/03. https://doi.org/10.1164/rccm.2107027 PMID: 12153963
49. Biernacki W, Gould GA, Whyte KF, Flenley DC. Pulmonary hemodynamics, gas exchange, and the
severity of emphysema as assessed by quantitative CT scan in chronic bronchitis and emphysema.
The American review of respiratory disease. 1989; 139(6):1509–15. Epub 1989/06/01. https://doi.org/
10.1164/ajrccm/139.6.1509 PMID: 2729756
50. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, et al. Percent emphysema, airflow
obstruction, and impaired left ventricular filling. The New England journal of medicine. 2010; 362
(3):217–27. Epub 2010/01/22. https://doi.org/10.1056/NEJMoa0808836 PMID: 20089972
51. Smith BM, Prince MR, Hoffman EA, Bluemke DA, Liu CY, Rabinowitz D, et al. Impaired Left Ventricular
Filling in COPD and Emphysema: Is It the Heart or the Lungs?: The Multi-Ethnic Study of Atherosclero-
sis COPD Study. Chest. 2013; 144(4):1143–51. https://doi.org/10.1378/chest.13-0183 PMID:
23764937
Pulmonary hyperinflation due to gas trapping and pulmonary artery size
PLOS ONE | https://doi.org/10.1371/journal.pone.0176812 May 2, 2017 14 / 14
